|Articles|April 20, 2023
Mass Spectra of Designer Drugs 2023
With a continued need for comprehensive forensic data to keep up with the rapid pace of designer drug synthesis, John Wiley & Sons have made a new mass spectral database designed for laboratory use. According to the company, this release features over 34,000 mass spectra of more than 26,000 unique chemical compounds with detailed information and chemical structures for each entry.
John Wiley & Sons, Inc.
Hoboken, New Jersey, USA
Related Content
Trending on LCGC International
1
AI/ML in Practice: Machine-learning Prediction of Chromatographic Retention Times for Small Molecules in Pharmaceutical Applications
2
Chromatography's Role in Spotting False Leachables
3
Background Contamination and the Limits of PFAS Detection
4
Fast GC-MS/MS Detects PFAS in Food Packaging
5